RELX (NYSE:RELX) Stock Rating Lowered by Wall Street Zen

RELX (NYSE:RELX) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Friday.

RELX Stock Performance

Shares of RELX stock opened at $47.04 on Friday. The firm has a market cap of $86.29 billion, a price-to-earnings ratio of 25.29, a PEG ratio of 3.05 and a beta of 0.87. The company’s 50 day moving average is $50.49 and its 200 day moving average is $51.20. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. RELX has a 52-week low of $44.19 and a 52-week high of $56.33.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Larson Financial Group LLC increased its stake in shares of RELX by 612.5% during the first quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock worth $26,000 after purchasing an additional 441 shares in the last quarter. WPG Advisers LLC purchased a new stake in shares of RELX during the first quarter worth about $28,000. Golden State Wealth Management LLC increased its stake in shares of RELX by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock worth $30,000 after purchasing an additional 294 shares in the last quarter. NewSquare Capital LLC grew its stake in RELX by 522.0% during the 2nd quarter. NewSquare Capital LLC now owns 566 shares of the technology company’s stock valued at $31,000 after acquiring an additional 475 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in RELX by 99.3% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock valued at $33,000 after acquiring an additional 303 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.

About RELX

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.